Metformin promotes anticancer activity of NK cells in a p38 MAPK dependent manner

Metformin, a drug prescribed to treat type 2 diabetes, has been reported to possess antitumor activity via immunity activation. However, the influence of metformin on natural killer (NK) cells is not fully understood. Here, we investigated whether metformin exerts a potent anticancer effect by activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, Wenjiao, Qi, Xin, Li, Mingfeng, Wu, Yu, Sun, Lulu, Fan, Xinglong, Yuan, Yuan, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565822/
https://www.ncbi.nlm.nih.gov/pubmed/34745769
http://dx.doi.org/10.1080/2162402X.2021.1995999

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565822/
https://www.ncbi.nlm.nih.gov/pubmed/34745769
http://dx.doi.org/10.1080/2162402X.2021.1995999

Ejemplares similares